Table 3.
Outcome | No. of studies | No. of eyes | Test for heterogeneity | Overall effect | |||||
---|---|---|---|---|---|---|---|---|---|
ILM peeling | ILM preserved | x 2 | I2 | P | WMD/RR (95 % CI) | Z | P | ||
Primary anatomic reattachment [9, 10, 15–18] | 6 | 219 | 138 | 8.15 | 38.6 % | 0.148 | 1.19(1.04, 1.36) | 2.52 | 0.012 |
Macular hole closure[14–18] | 5 | 127 | 83 | 2.47 | 0.0 % | 0.650 | 1.71 (1.20, 2.43) | 2.95 | 0.003 |
Improved BCVA at ≥6 months[14, 18] | 2 | 27 | 14 | 0.17 | 0.0 % | 0.677 | 0.06 (−0.31, 0.44) | 0.33 | 0.738 |
BCVA best corrected visual acuity, ILM internal limiting membrane, RR relative risk, WMD weighted mean difference